Evidence map›Paper›PMID 36416809›Full record

ArticleNanoscale2022

Anti-KIT DNA aptamer-conjugated porous silicon nanoparticles for the targeted detection of gastrointestinal stromal tumors.

Sanahan Vijayakumar, Seyedmehdi H Nasr, Jacob E Davis, Edward Wang, Jonathan M Zuidema, Yi-Sheng Lu, Yu-Hwa Lo, Jason K Sicklick, Michael J Sailor, Partha Ray

Open access · greenAbstract read
In one paragraph

Article in Nanoscale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sanahan VijayakumarMaterials Science and Engineering Program, University of California, San Diego, La Jolla, California, 92093, USA. msailor@ucsd.edu.
Seyedmehdi H NasrDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, California, 92093, USA.
Jacob E DavisDepartment of Surgery, Division of Surgical Oncology, University of California, San Diego, San Diego, California, 92093, USA. pray@health.ucsd.edu.
Edward WangMaterials Science and Engineering Program, University of California, San Diego, La Jolla, California, 92093, USA. msailor@ucsd.edu.ORCID http://orcid.org/0000-0001-6768-0440
Jonathan M ZuidemaDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, California, 92093, USA.ORCID http://orcid.org/0000-0003-2258-0045
Yi-Sheng LuMaterials Science and Engineering Program, University of California, San Diego, La Jolla, California, 92093, USA. msailor@ucsd.edu.
Yu-Hwa LoMaterials Science and Engineering Program, University of California, San Diego, La Jolla, California, 92093, USA. msailor@ucsd.edu.
Jason K SicklickDepartment of Surgery, Division of Surgical Oncology, University of California, San Diego, San Diego, California, 92093, USA. pray@health.ucsd.edu.
Michael J SailorMaterials Science and Engineering Program, University of California, San Diego, La Jolla, California, 92093, USA. msailor@ucsd.edu.ORCID http://orcid.org/0000-0002-4809-9826
Partha RayDepartment of Surgery, Division of Surgical Oncology, University of California, San Diego, San Diego, California, 92093, USA. pray@health.ucsd.edu.ORCID http://orcid.org/0000-0002-7075-5463
University of California San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
Targeting Drug-Resistant Cancer Stem Cell Niches of Gastrointestinal Stromal TumorR01CA226803 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SICKLICK, JASON KEITH · 2019 to 2023
$2.1M
JEOL JEM-1400Plus Transmission Electron MicroscopeS10OD023527 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FARQUHAR, MARILYN GIST · 2017 to 2017
$579k
NCATS NIH HHS UL1 TR001442NCI NIH HHS R01 CA226803NIH HHS S10 OD023527
6 · The paper itself

Abstract

Evaluation of Gastrointestinal Stromal Tumors (GIST) during initial clinical staging, surgical intervention, and postoperative management can be challenging. Current imaging modalities (

Indexed as

Aptamers, NucleotideGastrointestinal Stromal TumorsAnimalsMiceSiliconAptamers, NucleotideSilicon

Identifiers

PMID36416809
PMCPMC9744628
OpenAlexW4310333030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.